Evidence map›Paper›PMID 40332527›Full record

ReviewInternational journal of molecular sciences2025

Chromoplexy: A Pathway to Genomic Complexity and Cancer Development.

Franck Pellestor, Benjamin Ganne, Jean Baptiste Gaillard, Vincent Gatinois

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Franck PellestorChromosomal Genetics Unit and Chromostem Research Platform, Department of Molecular Genetics and Cytogenomics, Unique Site of Biology (SUB), University Hospital of Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.
Benjamin GanneChromosomal Genetics Unit and Chromostem Research Platform, Department of Molecular Genetics and Cytogenomics, Unique Site of Biology (SUB), University Hospital of Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.ORCID 0000-0001-5617-0023
Jean Baptiste GaillardChromosomal Genetics Unit and Chromostem Research Platform, Department of Molecular Genetics and Cytogenomics, Unique Site of Biology (SUB), University Hospital of Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.
Vincent GatinoisChromosomal Genetics Unit and Chromostem Research Platform, Department of Molecular Genetics and Cytogenomics, Unique Site of Biology (SUB), University Hospital of Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.ORCID 0000-0003-0480-6709

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromoplexy is a phenomenon of complex genome rearrangement, occurring during a single cell event and characterized by the formation of chain rearrangements affecting multiple chromosomes. Unlike other genomic rearrangements such as chromothripsis, which involves a single chromosome, chromoplexy affects several chromosomes at once, creating patterns of complex, balanced translocations, and leading to the formation of fusion genes and the simultaneous disruption of several genes. Chromoplexy was first identified in prostate cancers, but it is now observed in various cancers where gene fusions take place. The precise mechanisms behind chromoplexy remain under investigation. The occurrence of these rearrangements follows multiple double-stranded breaks that appear to occur in certain regions or during particular genome configurations (open chromatin, active transcription area), and which lead to an intricate series of inter- and intra-chromosomal translocations and deletions without significant alterations in the number of copies. Although chromoplexy is considered a very early event in oncogenesis, the phenomenon can be repeated and can constitute a mechanism of clonal tumor progression. The occurrence of chromoplexy supports the equilibrium model punctuated by tumor evolution, characterized by periods of relative stability punctuated by sudden and rapid periods of radical genomic changes.

Indexed as

CarcinogenesisNeoplasmsAnimalsChromosome AberrationsChromothripsisGene FusionGene RearrangementGenomicsHumansTranslocation, Geneticchromoanagenesischromoplexydeletiongene fusionprostate cancerpunctuated evolutiontranslocationtumor

Identifiers

PMID40332527
PMCPMC12027847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.